Xconomy Boston

Adimab, Inc. Receives $6,000,000 Series A Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ad20375f-027b-442f-8997-ec7e5dfce8f8&Preview=1
Date
7/20/2007
Company Name
Adimab, Inc.
Mailing Address
16 Cavendish Court Lebanon, NH 03766
Company Description
Adimab–which stands for Antibody Discovery Maturation Biomanufacturing–is developing a platform that’s deliberately engineered to minimize and potentially eliminate third party royalties, offering a one-stop-service-shop to a select few Big Pharma partners.
Website
http://www.adimab.com
Transaction Type
Venture Equity
Transaction Amount
$6,000,000
Transaction Round
Series A
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
SV Life Sciences
Venture Investor
Polaris Venture Partners